参考文献/References:
[1]Nelson AJ,Rochelau SK,Nicholls SJ.Managing Dyslipidemia in Type 2 Diabetes[J].Endocrinol Metab Clin Norrth Am,2018,47(1):153-173.
[2]Baez-Duarte BG,Zamora-Gínez I,González-Duarte R,et al.Triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index as a reference criterion of risk for metabolic syndrome(MetS) and low insulin sensitivity in apparetly healthy subjects[J].Gac Med Mex,2017,153(2):152-158.
[3]Petrie JR,Guzik TJ,Touyz RM.Diabetes,Hypertension,and Cardiovascular Disease:Clinical Insights and Vascular Mechanisms[J].Can J Cardiol,2018,34(5):575-584.
[4]Stinchcombe TE,Socinki MA.Treatment paradigms for advanced stage nonsmall cell lung cancer in the era of multiple lines of therapy[J].J Thoracic Oncol,2009,4(2):243-250.
[5]Kent BD,Mcnicholas WT,Ryan S.Insuiin resistance,glucose intolerance and diabetes mellitus in obstructive sleep apnoea[J].J Thorac Dis,2015,7(8):1343-1357.
[6]Hardie DG.Keeping the home fires burning:AMP-activated protein kinase[J].J R Soc Interface,2018,15(138):20170774.
[7]Greco C,Spallone V.Obstructive sleep Apnoea syndrome and Diabetes.Fortuitous Association or Interaction?[J].Curr Diabetes Rev,2015,12(2):129-155.
[8]Ceccato F,Bernkopf E,Scaroni C.Sleep apnea syndrome in endocrine clinics[J].Journal of Endocrinological Investigation,2015,38(8):827-834.
[9]Wu L,Parhofer KG.Diabetic dysljpidemia[J].MetaboIism,2014,63(12):1469-1479.
[10]Wang T,Xu Y,Xu M,et al.Awareness,treatment and control of cardiometabolic disorders in Chinese adults with diabetes:anational representative population study[J].Cardiovasc Diabetol,2015(14):28.
[11]李菁爽,张立海,王跃生,等.罗格列酮对初发2型糖尿病患者血糖、炎症因子和胰岛素抵抗的影响机制研究[J].中国医药导报,2013,10(8):19-21.
[12]刘小翠,潘海林.二甲双胍联合罗格列酮治疗肥胖2型糖尿病患者糖脂代谢及胰岛素抵抗的影响[J].广西医科大学学报,2010,27(3):434-436.
[13]曲颖,张纯利,胡文娟,等.西格列汀、罗格列酮分别联合二甲双胍治疗老年2型糖尿病的疗效观察[J].现代生物医学进展,2013,12(21):4077-4080.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(17):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(17):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(17):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(17):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(17):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(17):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(17):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(17):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(17):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]